• Wed news: Gilead HIV pipeline. Walgreens may go private. How Trump 2.0 will affect medtech. Lilly to offer Zepbound via Ro Telehealth. Pharma’s regulatory optimism. See more on our front page

How are sales going?

Quote






ROCK on Baby!! NPSP stock is on fire, thank you for not hiring me as I am making more on the stock than what your putrid offer was and I do nothing. Now I can with my Proxy vote out several of your board members who want to keep NPS an independent company. This company should be sold to the highest bidder and greedy fucks like myself will laugh all the way to the fucking bank, is this a great country or what. Why are you reading this....you should be planning you sales calls for tomorrow...see ya....

PS, really I am wishing all of you the very best of luck with your earnings call next week and I am not that much of an asshole, just ask my ex-wife.
 






Anonymous said:
ROCK on Baby!! NPSP stock is on fire, thank you for not hiring me as I am making more on the stock than what your putrid offer was and I do nothing. Now I can with my Proxy vote out several of your board members who want to keep NPS an independent company. This company should be sold to the highest bidder and greedy fucks like myself will laugh all the way to the fucking bank, is this a great country or what. Why are you reading this....you should be planning you sales calls for tomorrow...see ya....

PS, really I am wishing all of you the very best of luck with your earnings call next week and I am not that much of an asshole, just ask my ex-wife.
Click to expand...

congrats on not getting the job. enjoy your $800 Q1 bonus from GSK.
 






























expect company to show profit - no real R&D expense - we have global rights to Preotact/Natpara - already approved in EU selling $400 million per year. Gattex off like a total rocket should sell well over $200 million this year. Do the math BABY !!!! PROFIT CITY !!!!!!!!
 






Anonymous said:
There are 382 patients on therapy as of last night, with order/ship/reimbursement backlog of at least 230 more - well on our way to 1000 patients by June
Click to expand...

Well, the earnings call didn't have such rosy numbers (42) on therapy, but a good number in process. I thought there would be better numbers tha 654 thousand dollars sold for a drug that cost 295 K per year.

Singed, a Shareholder.
 






Why so negative ?? Gattex is off like a rocket - those 42 patients were probably all on the first day the drug was available. I've talked to a few sales reps who each have more than that number of new starts on the drug. They will easily break 300 million in sales this year.
 












Anonymous said:
It's party time - is it really sales when patients call their doctor and BEG !!! please prescribe NPS' new drug
Click to expand...

Then my stock would increase in value because NPS wouldn't have to spend for low life reps. like yourself if pt's. call and "BEG" MD's for Gattex. You stupid bastard how did you get hired over here?
 




































Top Bottom
Back
Quote